Harnessing The Power of
NK Cells to Defeat Cancer


News & Events

June 24th, 2020

Cytovia Therapeutics, Inc appoints Dr. Wei Li as Chief Scientific Officer to accelerate the development of iPSC CAR-NK Cell Therapy for Cancer

June 3rd, 2020

CYTOVIA Therapeutics and MACROMOLTEK to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2

April 7th, 2020

Cytovia CEO Dr. Daniel Teper Featured on MSQ Webinar Series

March 24th, 2020

Hebrew University to Collaborate with Cytovia Therapeutics on Natural Killer Cell Research

March 18th, 2020

Webcast: BIO CEO & Investor Conference

February 12th, 2020